Genetic study identifies new form of congenital muscular dystrophy
Scientists have discovered a new form of congenital muscular dystrophy caused by mutations in a previously un-linked gene.
List view / Grid view
News
Positive results for Viking’s rare diseases in vivo study
Viking Therapeutics announced positive initial results from a proof-of-concept study of VK2809 in an in vivo model of glycogen storage disease Ia (GSD Ia).
£100 million for Cancer Research’s ‘grand challenge’ competition winners
Cancer Research UK announced that four international teams are the first recipients of its global £100m Grand Challenge competition, which aims to overcome the biggest challenges facing cancer researchers in a global effort to beat cancer sooner.
Orexin as a potential drug for treating septic shock
Recent findings by Japanese scientists may be a breakthrough in developing a silver bullet for the treatment of septic shock.
Wellcome Trust gives Polyphor CHF 2.3 million for antibiotic development
Polyphor has received a CHF 2.3 million award from the Wellcome Trust to advance the development of broad-spectrum, Gram-negative pre-clinical product candidates.
BMBF funds Zika vaccine research group at LMU
The research group will explore novel approaches to vaccine development, focusing on the Zika virus.
Genmab appoints Judith Klimovsky as Chief Development Officer
The biotechnology company Genmab announced today the appointment of Judith Klimovsky, MD, as Executive Vice President and Chief Development Officer.
Molecular Devices introduces SpectraMax iD3 Multi-Mode Microplate Reader
Molecular Devices announced the launch of the new SpectraMax® iD3 Multi-Mode Microplate Reader, a cornerstone of a complete laboratory solution to help you expand the boundaries of your research capabilities...
Quotient Clinical acquires SeaView Research, the specialist clinical pharmacology business
Quotient Clinical announces that it has acquired SeaView Research, expanding its operations into the USA...
How to stop pain from serious burns using epigenetics
The unpleasant sensation sparked by the nervous system when confronted with a harmful stimulus can be alleviated by blocking a genetic marker that switches off the activity of the neurons involved.
Breath test could help detect stomach and oesophageal cancers
A test that measures the levels of five chemicals in the breath has shown promising results for the detection of oesophageal and stomach cancers, in a large patient trial.
‘Love hormone’ used a drug lead for inhibiting preterm labour
A team of scientists from Austria, Australia, Denmark, England and the Czech Republic, led by Christian Gruber from the MedUni Vienna's Institute of Pharmacology, managed to isolate a neuropeptide from ants that is very similar to the human love hormone oxytocin, and the closely related hormone vasopressin.
Colorectal metastases biomarker predicts patient survival
Liver metastases are formed from cancer cells that have originated in other organs and migrated to the liver via the bloodstream.
Oncolytic Virotherapy Europe Congress returns to London
The Oncolytic Virotherapy Europe Congress is the only conference in Europe dedicated specifically to the Oncolytic Virotherapy and converting research into the next generation of clinically-relevant virotherapeutics.
Lorenz Mayr joins Drug Discovery 2017 speaker lineup
Lorenz Mayr, esteemed Vice President and Global Head of Biological Reagents and Assay Development at AstraZeneca will be joining the expert speaker lineup for the launch conference on Drug Discovery. The event takes place on 27 and 28 April 2017 in London.